President Yoweri Kaguta Museveni has thrown his support behind Dr. Matthias Magoola and his pharmaceutical company, Dei Biopharma Ltd, praising the Ugandan scientist for making strides in medical innovation and pledging government backing to ensure his products reach global markets.
In a meeting held at State House earlier this week, President Museveni was briefed by Dr. Magoola on the progress of several ongoing biomedical projects.
Through his socials, the president wrote; “I met with Dr Matthias Magoola of Dei Biopharma Ltd who came to update me on a number of projects they are undertaking. I am happy to learn that he has filed over 100 patents with the United States Patent office for treating different diseases including cancer, HIV, Alzheimer’s, Malaria, TB, and Diabetes, some of which have been granted. The government will support his company with the necessary accreditation requirements in order to obtain licenses for drugs to be produced locally for use in global markets.”
I met with Dr Matthias Magoola of Dei Biopharma Ltd who came to update me on a number of projects they are undertaking.
— Yoweri K Museveni (@KagutaMuseveni) April 13, 2025
I am happy to learn that he has filed over 100 patents with the United States Patent office for treating different diseases including cancer, HIV,… pic.twitter.com/9pgMG6DWZs
Minister for the Presidency, Hon. Milly Babalanda also praised Dr. Magoola for what she described as a “big achievement” for Uganda and the wider scientific community.
“I congratulate Dr. Matthias Magoola upon securing a US patent for his cancer treatment drug,” Babalanda stated.
She added, “This is a big achievement and a step in the right direction for scientific innovation contributing to a better world.”
The Minister also expressed gratitude to President Museveni for his unwavering support of Dr. Magoola’s vision, including the establishment of a state-of-the-art pharmaceuticals factory in Matugga.
“I thank the President for believing in Dr. Magoola’s vision and supporting the setting up of the modern pharmaceuticals factory at Matugga for drugs and vaccines against various ailments including HIV/AIDS and sickle cell,” she noted.
Hon. Babalanda further called on Ugandans to take pride in locally driven innovation, urging, “As Ugandans, we should be proud and support our own,”
Dei BioPharma Ltd is a Uganda-funded research-based drugs and vaccines manufacturing firm located in Matugga, Wakiso District. It is the largest pharmaceutical manufacturing and also the first biotechnology products company that will introduce most advanced technologies such as mRNA, gene therapy, novel vaccines, and recombinant drugs, besides other essential medicines in Uganda that are compliant with stringent regulatory country good manufacturing practices.
Related posts:
- ‘From 18% to 5.1%’- Uganda Celebrates HIV Fight Progress, Eyes Final Goal
- INSIDE STORY! Why President Museveni Blocked Kabila from Using Ugandan Border to Access Goma
- Museveni Warns Ugandans Against Distracting Him with Unbudgeted Demands
- Uganda, South Sudan, CAR Ink Deal to Boost Regional Trade, Connectivity
